Clinical trial of tolerability, safety, and immunogenicity of the Russian influenza inactivated split vaccine Flu-m in children from 6 months to 9 years of age

Clinical trial of tolerability, safety, and immunogenicity of the Russian influenza inactivated split vaccine Flu-m in children from 6 months to 9 years of age

Purpose: To study the reactogenicity, safety and immunogenicity of the Russian vaccine Flu-M in comparison with Vaxigrip vaccine for influenza prevention in children aged from 6 months to 9 years (phase III).Materials and Methods. In 2021, a clinical study was conducted in which children aged 6 mont...

Full description

Saved in:
Bibliographic Details
Main Authors: A. M. Korolyuk, L. A. Zazimko, V. N. Kraeva, Yu. A. Koromzin, E. A. Ruzanova, A. A. Ekimov, N. N. Savina, E. V. Ryskova, V. P. Trukhin
Format: Article
Language:Russian
Published: Journal Infectology 2023-10-01
Series:Журнал инфектологии
Subjects:
safety
reactogenicity
immunogenicity
flum and vaxigrip vaccines
children from 6 months to 9 years of age
Online Access:https://journal.niidi.ru/jofin/article/view/1544
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journal.niidi.ru/jofin/article/view/1544

Similar Items